Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 191 Magnetic Resonance Spectroscopy 141 Biopsy 102 pembrolizumab 85 Carboplatin 79 Cisplatin 71 Nivolumab 64 Paclitaxel 52 Radiotherapy 51 Gemcitabine 51 Cyclophosphamide 48 Dexamethasone 47 durvalumab 39 Radiation 39 atezolizumab 38 Pemetrexed 38 olaparib 34 Rituximab 34 venetoclax 33 Etoposide 33 Lenalidomide 32 Doxorubicin 32 Bevacizumab 32 X-Rays 30 Prednisone 30 Docetaxel 30 Disulfides 28 Ipilimumab 27 Immunoglobulin G 27 Fluorouracil 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × EC regimen × 30 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡